Somerville, MA, United States of America

Joseph Tyler

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2004-2018

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Joseph Tyler: Innovator in Polymer Tablet Technology

Introduction

Joseph Tyler is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of polymer tablet cores. With a total of 4 patents to his name, Tyler's work has advanced the methods of producing effective and efficient tablet formulations.

Latest Patents

One of Tyler's latest patents focuses on a direct compression polymer tablet core. This invention provides a tablet core that comprises at least about 95% by weight of an aliphatic amine polymer. The method of producing this tablet core involves compressing the aliphatic amine polymer to form the core. Additionally, the tablet core can include one or more excipients. The production method includes hydrating the polymer to the desired moisture level, blending it with excipients, and compressing the blend to form the tablet core. Furthermore, the invention relates to a coated tablet that features an aliphatic amine polymer core with a water-based coating.

Career Highlights

Joseph Tyler is currently employed at Genzyme Corporation, where he continues to innovate in the field of pharmaceutical technology. His work has been instrumental in enhancing the efficiency and effectiveness of tablet formulations, contributing to better patient outcomes.

Collaborations

Tyler collaborates with various professionals in his field, including his coworker John S. Petersen. Their combined expertise fosters an environment of innovation and advancement in pharmaceutical technologies.

Conclusion

Joseph Tyler's contributions to polymer tablet technology exemplify the impact of innovation in the pharmaceutical industry. His patents and ongoing work at Genzyme Corporation highlight his commitment to improving medication delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…